ArticleClinical kidney journal2021

Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis.

Hirokazu Honda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.